Try our Advanced Search for more refined results
October 14, 2013
Track this case
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
A Delaware bankruptcy judge on Monday blessed Savient Pharmaceuticals Inc.'s Chapter 11 liquidation plan, allowing the estate of the former drug developer to distribute $120 million in sale proceeds and other remaining assets among its creditors.
Already a subscriber? Click here to login